Acute rejection occurs in most of the patients undergoing organ transplantation. The new organ, unable to thwart the action, starts showing symptoms of organ failure.
-
Nulojix (Belatacept) was developed by Bristol Myers Squibb and is indicated... -
The drug was approved by the US FDA and in European Union in June 2011 for... -
Kidney transplantation is usually performed in patients with chronic kidney... -
Acute rejection occurs in most of the patients undergoing organ...
